Eight Series A diligence questions — answered with the same evidence base a reviewer audits.
Redoubt Fastener Co. is raising a $50M Series A at an $80M pre-money valuation. The eight Q&A pairs below cover the top-line diligence questions a lead investor brings to a first call — market size, the DFARS and Berry-Amendment compliance moat, manufacturing readiness, use of proceeds, cap table, traction, competitive differentiation, and the exit thesis. Each answer rests on the same per-lot evidence base the procurement trail travels with and the data room is disclosed against.
Frequently asked questions.
The eight Q&A pairs below are the answers the Series A lead-investor desk carries into a first call. Each answer resolves to the same evidence base — per-lot compliance posture, the cap-table summary, the three-statement model, the IP and patent posture, the prime-pilot trail, and the operating quality system — that the data room is built around.
- How large is the addressable market, and how do you size it?
- The addressable footprint sits between each prime’s existing single-source fastener vendor and the next surge or audit event. We size bottom-up by defense program (DFARS specialty-metals and Berry-Amendment covered platforms) at the fastener-line level, cross-checked against top-down specialty-alloy fastener procurement spend. The bottom-up and top-down views reconcile to the same addressable footprint — domestic second-source supply for DFARS-covered fastener systems on programs carrying documented sole-source exposure. Per-program and per-alloy breakdowns ship in the data-room financial model under an executed NDA.
- What is the DFARS / Berry-Amendment compliance moat?
- Defense fastener programs rarely admit a greenfield supplier without a documented compliance chain. Redoubt ships per-lot Berry-compliance statements tied to a named end-product with a component-percentage test, and the DFARS specialty-metals carve-out covers stainless and alloy steel melt and pour performed in covered countries. The same evidence base is what a contracting-officer reviewer vets at audit and what a DCMA review cites as the source of supply. A second-source that cannot present this posture on intake has to rebuild it before quoting — we ship it as part of the response trail.
- What is the manufacturing readiness state today?
- We are operational: a registered CAGE code with active SAM.gov entity, an ISO 9001:2015 quality system, AS9100D-aligned flow, and a per-lot traceability chain from melt to delivery. Sample qualification cadence is alloy-dependent — CRES 2–4 weeks, titanium 4–6 weeks, specialty alloy 4–8 weeks. The Series A deployment is the capex build that brings a CNC cell expansion and a heat-treat line online to scale per-alloy throughput. The qualification evidence base and the post-Series-A capacity plan are disclosed in the data room under NDA.
- How will Series A proceeds be deployed?
- Four working buckets: (1) manufactured capex — CNC cell expansion and a domestic heat-treat line tied to the new throughput; (2) commercial GTM — defense sales engineers and channel partners; (3) engineering — alloys coverage, drawings library, and QA systems; (4) working capital — inventory build and accounts-receivable financing. Per-bucket share is finalized post-commit, ahead of the data-room release; each line ships carrying a pending-close flag on the share figure until the financing closes.
- What does the current cap table look like?
- Ownership classes, authorized shares, dilution math post-close, founder / executive / director / stakeholder lines, DTC-eligible vs. holder-of-record positions, and the pre-money vs. post-money share splits are disclosed in the data-room cap table summary under NDA execution. The data-room tabulation covers pro forma fully-diluted ownership post-Series A close; the pre-money table on the Series A briefing page reflects the current state at filing.
- What traction and commercial signal can you cite today?
- Six operational milestones are verifiably in market: (1) Berry-compliance intake live at /berry-compliance, with per-lot Berry-compliance statements tied to a named end-product; (2) DFARS fastener catalog shipped at /dfars-fasteners, with specialty-metals carve-outs documented alloy by alloy; (3) sample-request intake is live (POST /api/contact, kind=sample-request); (4) ADM (Army Deployment Medicine) contact channel opened; (5) CAGE code registered and SAM.gov entity active; (6) torque / tensile reference library is live at /technical-resources. Items still in motion — pilot conversion to PO, third-party validation — carry a pending-close flag so the trial is clean.
- How are you differentiated from incumbent fastener suppliers?
- Three commitments travel with every procurement walk-through: (1) DFARS part-number equivalents cross-referenced on intake so the lot traceability chain starts with the right registration record; (2) Berry-compliance statements attached per cert chain, not aggregated at the contract level, so the compliance trail travels with the shipment and survives audit; (3) AS9100D-aligned procurement flow on an ISO 9001:2015 quality system, supporting stock DFARS catalog items and engineered specials in the same flow. The combined posture — per-lot documentation, US-based capacity, and a flow that supports catalog and engineered specials in one lane — is the differentiation an incumbent with sole-source exposure is buying.
- What is the exit thesis for Series A investors?
- The defensible second-source position on a concentrated, dual-sourceable, policy-anchored defense fastener market provides several paths to a liquidity event at scale. Strategic acquirers — domestic primes consolidating their fastener supply base, larger defense industrial-base groups seeking scaled Berry-and-DFARS capacity, Tier 1 integrators absorbing upstream capacity for sole-source exposure — represent the most likely exit lane. A scaled domestic fastener manufacturing base with a documented Berry / DFARS posture, ISO/AS quality system certifications, and active prime-contractor pilots is a scarce asset in the reshoring cycle, and the most relevant comparable transactions sit in defense industrial-base M&A through the highest-revenue channel. The detailed thesis, with comparable transactions, ships in the data-room cap-table summary.
Related documentation.
Two companion pages round out the Series A walk — the briefing page carries the positioning, traction, and use-of-funds narrative, and the data room is the working table of contents for the redacted review package behind the answers above.
Series A briefing
Positioning, traction, use of funds, the structured NDA intake, and the Series A briefing for lead investors evaluating the Redoubt raise.
OpenData Room
The Series A data room is the working table of contents for the redacted review package — cap table, three-statement model, IP and patent posture, customer pilots, NTAG/QA stack, sample SOWs, and the mock definitive-agreement form. Access on mutual NDA execution.
OpenWhat the diligence desk does next.
After the Q&A walk, the diligence desk moves to the data room — under NDA execution — for the cap-table summary, the three-statement model, the IP and patent posture, the prime-pilot trail, the NTAG/QA stack, and the mock definitive-agreement form. Each item is the evidence base a reviewer audits against before a term sheet.
Berry / DFARS evidence base
The compliance statements attached to each per-lot cert chain are the same evidence base the data-room documentation and the procurement trail travel with. Investors cite this posture in supply-chain risk memos and at DCMA reviews.
Prime-pilot trail & quality system
Prime-contractor pilot programs (ADM channel open, additional primes pending), the ISO 9001:2015 quality system, and the AS9100D-aligned flow are the operating trail a reviewer verifies before signing a term sheet.